As congressional hearing looms, Sanofi cuts insulin prices for some patients
PAUL GRIGGS/WELLCOME IMAGES
The move is the latest bid to deflect intensifying criticism of the cost of medicines, but particularly insulin, which has nearly tripled in recent years.
.png)
No hay comentarios:
Publicar un comentario